Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05318027 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

ChatBot and Activity Monitoring in Patients Undergoing Chemoradiotherapy

StatusActive, Not Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Dec 2025 to Dec 2026 Trial status: Recruiting to Active, Not Recruiting · Site details revisedv9 Show 2 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
  2. Phase: Not applicable to Phase 2v8
  3. Primary completion date: Feb 2025 to Dec 2025 Completion date: May 2025 to Dec 2025v7 Show 1 more changeShow less
    • Completion date: May 2025 to Dec 2025
  4. Primary completion date: Feb 2024 to Feb 2025 Completion date: May 2024 to May 2025v6 Show 1 more changeShow less
    • Completion date: May 2024 to May 2025
  5. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 1 · Start date changed from estimate of Jun 2023 to May 22, 2023v5 Show 2 more changesShow less
    • Study sites: 0 to 1
    • Start date changed from estimate of Jun 2023 to May 22, 2023
Show 3 earlier versionsHide 3 earlier versions
  1. Primary completion date: Feb 2023 to Feb 2024 Start date: Jan 2023 to Jun 2023 · Completion date: Feb 2023 to May 2024v4 Show 2 more changesShow less
    • Start date: Jan 2023 to Jun 2023
    • Completion date: Feb 2023 to May 2024
  2. Start date: Aug 2022 to Jan 2023v3
  3. Start date: May 2022 to Aug 2022v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Evaluate the feasibility of using a chatbot combined with continuous activity monitoring to proactively identify, appropriately triage and help manage patients' symptoms during cancer treatment Determine whether such an early outpatient clinic-based intervention can decrease rates of excess triage visits Correlate changes in activity and early symptom management to emergency department visits, unplanned inpatient hospitalizations and treatment breaks
Trial Details
NCT Number NCT05318027
Lead Sponsor Abramson Cancer Center at Penn Medicine
Conditions Lung Cancer, Gastrointestinal Cancer, Head and Neck Cancer
Enrollment 70 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov